GSK's COPD treatment approved by FDA
23rd May 2025 07:20
(Sharecast News) - Pharma group GSK has announced that US regulators have approved for use its Nucala treatment for adults with chronic obstructive pulmonary disease (COPD) following positive results from phase III trials.
Read moreGSK's blood cancer treatment approved in Japan
19th May 2025 07:41
(Sharecast News) - GSK's Blenrep treatment has been approved by Japanese regulators when in combination for relapsed or refractory multiple myeloma, marking the second major approval of its kind for the drug, with more expected in 2025.
Read moreLondon close: Stocks finish choppy week in the black
16th May 2025 16:32
(Sharecast News) - London equities ended the week higher on Friday, supported by gains in pharmaceutical and energy stocks.
Read moreGSK buys Boston's developmental liver disease drug for up to $2bn
14th May 2025 07:18
(Sharecast News) - GSK announced on Wednesday that it has entered into an agreement with Boston Pharmaceuticals to acquire its lead asset Efimosfermin for up to $2bn, buying a specialty medicine to treat and prevent progression of steatotic liver disease (SLD).
Read morePharma stocks slide as Trump threatens price cuts in US
12th May 2025 10:13
(Sharecast News) - Shares in pharmaceutical companies fell on Monday after US President Donald Trump threatened to sign an executive order to slash the price of prescription drugs for Americans.
Read moreSunday newspaper round-up: US-China, Aerospace, Pharma
11th May 2025 14:38
(Sharecast News) - The US president said talks with China that were taking place in Geneva had achieved a "total reset" in the two countries' trade relations. Without elaborating, Donald Trump said that great progress had been made and that they wanted to see an opening up of China to American businesses. The negotiations were scheduled to continue on Sunday. - Guardian
Read moreLondon close: FTSE snaps 16-day win streak ahead of Fed
7th May 2025 15:05
(Sharecast News) - London stocks ended lower on Wednesday, with the top-flight index snapping a 16-day winning streak as investor caution ahead of the US Federal Reserve's policy decision weighed on sentiment.
Read moreGSK, AstraZeneca slide after FDA unveils new vaccine lead
7th May 2025 11:32
(Sharecast News) - Shares in GSK and AstraZeneca came under pressure on Wednesday, after vaccine-sceptic Vinay Prasad was appointed to a key role at the US Food and Drug Administration.
Read moreGSK's Nucala delivers positive outcomes in published trial results
1st May 2025 09:54
(Sharecast News) - GSK announced on Thursday that its monoclonal antibody 'Nucala', or mepolizumab, delivered a statistically significant and clinically meaningful reduction in exacerbations for patients with chronic obstructive pulmonary disease (COPD), according to final results from the phase three MATINEE trial published in the New England Journal of Medicine.
Read moreLondon close: Stocks finish higher as US economy contracts
30th Apr 2025 14:52
(Sharecast News) - London stocks extended their gains on Wednesday, after fresh data from the US showed a slowing in consumer price growth, alongside the country's first economic contraction since 2022.
Read moreGSK confirms guidance after strong first quarter
30th Apr 2025 07:02
(Sharecast News) - GSK reiterated shrugged off the potential impact of tariffs on Wednesday and reiterated its full-year outlook, following a strong start to the year.
Read moreTwo GSK vaccines get US CDC recommendations
17th Apr 2025 07:27
(Sharecast News) - GSK announced two important endorsements from the US Centers for Disease Control and Prevention's (CDC) Advisory Committee on Immunization Practices (ACIP) on Thursday, for its vaccines Penmenvy and Arexvy, potentially expanding protection against meningococcal disease and respiratory syncytial virus (RSV) for millions of Americans.
Read moreLondon close: Stocks fall as China retaliates to latest US tariffs
9th Apr 2025 15:07
(Sharecast News) - London stocks fell sharply on Wednesday, with investors reacting to heightened geopolitical tensions after China unveiled retaliatory tariffs in response to a sweeping 104% import charge on Chinese goods announced by US president Donald Trump overnight.
Read moreLondon close: Stocks slide in global reaction to Trump tariffs
3rd Apr 2025 15:29
(Sharecast News) - London stocks closed sharply lower on Thursday as global markets reacted negatively to US president Donald Trump's unexpectedly aggressive global tariff policy announced overnight.
Read moreUK pharma stocks avoid selloff
3rd Apr 2025 10:18
(Sharecast News) - GSK and AstraZeneca avoided the selloff on Thursday as pharmaceutical products were exempt from Donald's Trump's tariffs.
Read more